東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Development and Validation of the Hu...

Lundin, Brady F.

FindBook

Google Book

Amazon

博客來

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening./
作者:	Lundin, Brady F.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2024,
面頁冊數:	98 p.
附註:	Source: Dissertations Abstracts International, Volume: 85-11, Section: B.
Contained By:	Dissertations Abstracts International85-11B.
標題:	Bioengineering. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31239092
ISBN:	9798382404998

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.
Lundin, Brady F.

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening. - Ann Arbor : ProQuest Dissertations & Theses, 2024 - 98 p.

Source: Dissertations Abstracts International, Volume: 85-11, Section: B.

Thesis (Ph.D.)--The University of Wisconsin - Madison, 2024.

Neural tube defects are the second most common congenital malformation and inflict significant morbidity and mortality upon affected patients. The mechanisms by with they form are unclear and traditional methods of studying the nascent central nervous system have significant limitations. Neural organoids have revolutionized how human neurodevelopmental disorders are studied. Yet, their utility for screening complex neural tube defect etiologies and potential prophylactics is limited by a lack of scalable and quantifiable derivation formats. Here, a brief introduction to neural tube formation and an overview of the known causes of neural tube defects is presented. Then a survey of the rapidly developing field of neural organoids is provided. After which, we describe the Rosette Array platform's ability to be used as an off-the-shelf, 96-well plate assay that standardizes incipient forebrain and spinal cord organoid morphogenesis as micropatterned, 3-D, singularly polarized neural rosette tissues. Rosette Arrays are seeded from cryopreserved human pluripotent stem cells, cultured over 6-8 days, and immunostained images can be quantified using artificial intelligence-based software. We demonstrate the platform's suitability for screening genetic and environmental factors known to cause neural tube defect risk. Lastly, the discussion closes by considering the implications of the platform's development and screening results and future research directions regarding understanding and preventing neural tube defect formation.

ISBN: 9798382404998Subjects--Topical Terms:

657580
Bioengineering.
Subjects--Index Terms:

Disease modeling

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.
LDR:02818nmm a2200421 4500 001 2403658
005 20241118135905.5
006 m o d
007 cr#unu||||||||
008 251215s2024 ||||||||||||||||| ||eng d
020 $a 9798382404998
035 $a (MiAaPQ)AAI31239092
035 $a AAI31239092
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lundin, Brady F. $3 3773929
245 1 0 $a Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 98 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-11, Section: B.
500 $a Advisor: Ashton, Randolph S.
502 $a Thesis (Ph.D.)--The University of Wisconsin - Madison, 2024.
520 $a Neural tube defects are the second most common congenital malformation and inflict significant morbidity and mortality upon affected patients. The mechanisms by with they form are unclear and traditional methods of studying the nascent central nervous system have significant limitations. Neural organoids have revolutionized how human neurodevelopmental disorders are studied. Yet, their utility for screening complex neural tube defect etiologies and potential prophylactics is limited by a lack of scalable and quantifiable derivation formats. Here, a brief introduction to neural tube formation and an overview of the known causes of neural tube defects is presented. Then a survey of the rapidly developing field of neural organoids is provided. After which, we describe the Rosette Array platform's ability to be used as an off-the-shelf, 96-well plate assay that standardizes incipient forebrain and spinal cord organoid morphogenesis as micropatterned, 3-D, singularly polarized neural rosette tissues. Rosette Arrays are seeded from cryopreserved human pluripotent stem cells, cultured over 6-8 days, and immunostained images can be quantified using artificial intelligence-based software. We demonstrate the platform's suitability for screening genetic and environmental factors known to cause neural tube defect risk. Lastly, the discussion closes by considering the implications of the platform's development and screening results and future research directions regarding understanding and preventing neural tube defect formation.
590 $a School code: 0262.
650 4 $a Bioengineering. $3 657580
650 4 $a Neurosciences. $3 588700
650 4 $a Developmental biology. $3 592588
650 4 $a Biomedical engineering. $3 535387
650 4 $a Immunology. $3 611031
653 $a Disease modeling
653 $a Human pluripotent stem cell
653 $a Neural development
653 $a Neural rosettes
653 $a Neural tube defects
653 $a Tissue engineering
690 $a 0202
690 $a 0317
690 $a 0758
690 $a 0541
690 $a 0982
710 2 $a The University of Wisconsin - Madison. $b Biomedical Engineering. $3 3192572
773 0 $t Dissertations Abstracts International $g 85-11B.
790 $a 0262
791 $a Ph.D.
792 $a 2024
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31239092